Tuberculose intestinal e peritoneal, apresentação incomum de tuberculose disseminada em paciente com talassemia, relato de caso.

Autores

DOI:

https://doi.org/10.22516/25007440.942

Palavras-chave:

tuberculose, talassemia, glutationa, ferro, relato de caso

Resumo

Introdução: A tuberculose é uma doença infecciosa prevenível e curável associada a alta morbimortalidade, a apresentação da tuberculose disseminada é rara e está associada a patologias que comprometem o sistema imunológico. Atualmente, existem poucos relatos de tuberculose disseminada e doenças congênitas subjacentes.
Caso clínico: Paciente com história de beta-talassemia que deu entrada por dor abdominal e sintomas constitucionais com diagnóstico final de tuberculose disseminada. Caso de particular interesse pela apresentação atípica, pela suspeita diagnóstica inicial de malignidade e extenso envolvimento da doença, embora o paciente não tivesse histórico de imunossupressão.
Conclusões: A tuberculose disseminada em pacientes imunocompetentes é uma apresentação rara associada a desfechos adversos. Uma história de beta-talassemia pode ser um fator de risco a ser considerado com base nas vias metabólicas envolvidas na fisiopatologia de ambas as doenças

Downloads

Não há dados estatísticos.

Biografia do Autor

Nicolás Téllez Castillo, Hospital universitario San Ignacio

Médico general, residente de medicina interna. Bogotá, Colombia.

Catherin Vanessa Tovar Sánchez, Hospital Universitario San Ignacio

Médico general, residente de medicina interna. Bogotá, Colombia.

Anggie Vélez Bohórquez, Hospital Universitario San Ignacio

Médico general, residente de patología. Bogotá, Colombia.

Paola Andrea Roa Ballestas, Hospital Universitario San Ignacio

Médico internista y gastroenteróloga. Bogotá, Colombia.

Ivan Enrique Gonzalez Mendoza, Hospital Universitario San Ignacio

Medico internista , fellow de gastroenterología y endoscopia. Bogotá, Colombia.

Referências

WHO Global Tuberculosis Programme. TB: a global emergency, WHO report on the TB epidemic [Internet]. Geneva: World Health Organization; 1994 [consultado el 11 de julio de 2022]. Disponible en: https://apps.who.int/iris/handle/10665/58749

Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;393(10181):1642–56. https://doi.org/10.1016/S0140-6736(19)30308-3

Natarajan A, Beena PM, Devnikar AV, Mali S. A systemic review on tuberculosis. Indian J Tuberculosis. 2020;67(3):295–311. https://doi.org/10.1016/j.ijtb.2020.02.005

World Health Organization. Global tuberculosis report 2021 [Internet]. Geneva: World Health Organization; 2021 [onsultado el 11 de julio de 2022]. Disponible en: https://apps.who.int/iris/handle/10665/346387

Ugarte-Gil C, Carrillo-Larco RM, Kirwan DE. Latent tuberculosis infection and non-infectious co-morbidities: Diabetes mellitus type 2, chronic kidney disease and rheumatoid arthritis. International J Infect Dis. 2019;80:S29–31. https://doi.org/10.1016/j.ijid.2019.02.018

Khan FY. Review of literature on disseminated tuberculosis with emphasis on the focused diagnostic workup. J Family Community Med. 2019;26(2):83-91. https://doi.org/10.4103/jfcm.JFCM_106_18

Baby J, Poovathingal S, Valsalan P, Sunila E. Atypical Presentation of Disseminated Tuberculosis. Journal of the Royal College of Physicians of Edinburgh. 2020;50(4):405–7. https://doi.org/10.4997/jrcpe.2020.411

García-Rodríguez JF, Álvarez-Díaz H, Lorenzo-García MV, Mariño-Callejo A, Fernández-Rial Á, Sesma-Sánchez P. Extrapulmonary tuberculosis: epidemiology and risk factors. Enfermedades Infecciosas y Microbiología Clínica. 2011;29(7):502-9. https://doi.org/10.1016/j.eimc.2011.03.005

Pang Y, An J, Shu W, Huo F, Chu N, Gao M, et al. Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008–2017. Emerging Infectious Diseases. 2019;25(3):457-64. https://doi.org/10.3201/eid2503.180572

Meira L, Chaves C, Araújo D, Almeida L, Boaventura R, Ramos A, et al. Predictors and outcomes of disseminated tuberculosis in an intermediate burden setting. Pulmonology. 2019;25(6):320–7. https://doi.org/10.1016/j.pulmoe.2018.11.001

Wang JY, Hsueh PR, Wang SK, Jan IS, Lee LN, Liaw YS, et al. Disseminated Tuberculosis. Medicine. 2007;86(1):39–46. https://doi.org/10.1097/MD.0b013e318030b605

Taher AT, Musallam KM, Cappellini MD. β-Thalassemias. New Eng J Med. 2021;384(8):727-43. https://doi.org/10.1056/NEJMra2021838

Wise J. WHO identifies 16 countries struggling to control tuberculosis. BMJ. 1998;316(7136):957. https://doi.org/10.1136/bmj.316.7136.955e

Fucharoen S, Winichagoon P. Haemoglobinopathies in southeast Asia. Indian J Med Res. 2011;134(4):498–506. http://www.ncbi.nlm.nih.gov/pubmed/22089614

Sriwijitalai W, Wiwanitkit V. Tuberculosis in patients with underlying thalassemia: a consideration of common antioxidative pathway − an expressional analysis. Egyptian Journal of Chest Disease and Tuberculosis. 2021;70(1):38-9. https://doi.org/10.4103/ejcdt.ejcdt_159_19

Ruoqiong C, Garrett T, Hicret I, Rachel A, Shalok M, Karo G, et al. Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis. Antimicrobial Agents and Chemotherapy. 2018;62(11):e01132-18. https://doi.org/10.1128/AAC.01132-18

Chakraborty I, Mitra S, Gachhui R, Kar M. Non-haem iron-mediated oxidative stress in haemoglobin E beta-thalassaemia. Ann Acad Med Singap. 2010;39(1):13-6. http://www.ncbi.nlm.nih.gov/pubmed/20126808

Kalpravidh RW, Tangjaidee T, Hatairaktham S, Charoensakdi R, Panichkul N, Siritanaratkul N, et al. Glutathione redox system in β -thalassemia/Hb E patients. ScientificWorldJournal. 2013;2013:543973. https://doi.org/10.1155/2013/543973

Gluba-Brzózka A, Franczyk B, Rysz-Górzyńska M, Rokicki R, Koziarska-Rościszewska M, Rysz J. Pathomechanisms of Immunological Disturbances in β-Thalassemia. International Journal of Molecular Sciences. 2021;22(18):9677. https://doi.org/10.3390/ijms22189677

Khan FA, Fisher MA, Khakoo RA. Association of hemochromatosis with infectious diseases: expanding spectrum. International Journal of Infectious Diseases. 2007;11(6):482-7. https://doi.org/10.1016/j.ijid.2007.04.007

Gangaidzo IT, Moyo VM, Mvundura E, Aggrey G, Murphree NL, Khumalo H, et al. Association of Pulmonary Tuberculosis with Increased Dietary Iron. The Journal of Infectious Diseases. 2001;184(7):936–9. https://doi.org/10.1086/323203

Centers for Disease Control and Prevention. Latent Tuberculosis Infection: a Guide for Primary Health Care Providers. Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis Elimination, 2020. [Consultado el 11 de julio de 2022]. Disponible en:https://www.cdc.gov/tb/publications/ltbi/pdf/LTBIbooklet508.pdf

Ottenhoff THM, Verreck FAW, Hoeve MA, van de Vosse E. Control of human host immunity to mycobacteria. Tuberculosis. 2005;85(1-2):53–64. https://doi.org/10.1016/j.tube.2004.09.011

Lounis N, Truffot-Pernot C, Grosset J, Gordeuk VR, Boelaert JR. Iron and Mycobacterium tuberculosis infection. Journal of Clinical Virology. 2001;20(3):123–6. https://doi.org/10.1016/S1386-6532(00)00136-0

Ghozali M, Dewi SP, Ghrahani R, Maskoen AM, Reniarti L, Sahiratmadja E, et al. Natural resistance-associated macrophage protein 1 gene polymorphisms in thalassemia patients with tuberculosis infection. Paediatr Indones. 2016;56(2):84-9. https://doi.org/10.14238/pi56.2.2016.84-9

Agrawal A, Shrivastava J, Singh A. Multidrug-resistant tubercular liver abscess in β-thalassemia. Indian Pediatr. 2014;51(5):401-2.

Hanafiah M, Mukhari SAM, Mustapha AM, Mumin NA. Intraventricular tuberculosis abscess in an immunocompromised patient: clinical vignette. Asian Biomedicine. 2021;15(6):293-7. https://doi.org/10.2478/abm-2021-0036

Harahap S, Pramudita A, Lusiani. Cardiac tamponade as a manifestation of extrapulmonary tuberculosis in β thalassemia major patient. IOP Conference Series. 2018;125: 012120. https://doi.org/10.1088/1755-1315/125/1/012120

Kataria SP, Avasthi R. Sternal tuberculosis in combination with thalassmia. J Assoc Physicians India. 1993;41(7):472.

Chit Yee D, Aung HKK, Mg Mg B, Htun WPP, Janurian N, Bancone G, et al. Case Report: A case report of multiple co-infections (melioidosis, paragonimiasis, Covid-19 and tuberculosis) in a patient with diabetes mellitus and thalassemia-trait in Myanmar. Wellcome Open Research. 2022;7:160. https://doi.org/10.12688/wellcomeopenres.17881.1

Figura 2. Colitis granulomatosa con hematoxilina y eosina. A. 4x, mucosa colónica, las flechas señalan granulomas. B. 10x, en la lámina propia se observa la formación de granulomas bien delimitados y algunos abscesos de neutrófilos. C. 40x, granuloma epitelioide. Fuente: historia clínica del paciente.

Publicado

2023-06-22

Como Citar

Téllez Castillo, N., Tovar Sánchez, C. V., Vélez Bohórquez, A., Roa Ballestas, P. A., & Gonzalez Mendoza, I. E. (2023). Tuberculose intestinal e peritoneal, apresentação incomum de tuberculose disseminada em paciente com talassemia, relato de caso. Revista Colombiana De Gastroenterologia, 38(2), 221–228. https://doi.org/10.22516/25007440.942

Edição

Seção

Reporte de Casos

Métricas

Crossref Cited-by logo
Métricas do artigo
Vistas abstratas
Visualizações da cozinha
Visualizações de PDF
Visualizações em HTML
Outras visualizações
QR Code